BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37294527)

  • 1. LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis.
    Qian L; Li L; Li Y; Li S; Zhang B; Zhu Y; Yang B
    Breast Cancer Res Treat; 2023 Aug; 200(3):375-390. PubMed ID: 37294527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOTAIR enhances breast cancer radioresistance through facilitating HSPA1A expression via sequestering miR-449b-5p.
    Zhang S; Wang B; Xiao H; Dong J; Li Y; Zhu C; Jin Y; Li H; Cui M; Fan S
    Thorac Cancer; 2020 Jul; 11(7):1801-1816. PubMed ID: 32374522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
    Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
    J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a lncRNA-mediated ceRNA network and a genomic-clinicopathologic nomogram to predict survival for breast cancer patients.
    Wu M; Lu L; Dai T; Li A; Yu Y; Li Y; Xu Z; Chen Y
    Cancer Biomark; 2023; 36(1):83-96. PubMed ID: 36591654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
    Wang T; Zhang XD; Hua KQ
    Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network.
    Shi W; Hu D; Lin S; Zhuo R
    Biomed Res Int; 2020; 2020():9081852. PubMed ID: 32964046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel lncRNA-miRNA-mRNA competing endogenous RNA network associated with prognosis of breast cancer.
    Wan X; Hao S; Hu C; Qu R
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23089. PubMed ID: 35532246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset.
    Wang X; Gao C; Feng F; Zhuang J; Liu L; Li H; Liu C; Wu J; Zheng X; Ding X; Sun C
    Biomed Res Int; 2020; 2020():4078596. PubMed ID: 32775417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
    Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
    [No Abstract]   [Full Text] [Related]  

  • 16. LINC01234 promoted malignant behaviors of breast cancer cells via hsa-miR-30c-2-3p/CCT4/mTOR signaling pathway.
    Tang C; Li C; Chen C; Chen T; Zhu J; Sun M; Wang P; Han C
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):46-56. PubMed ID: 38216268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
    Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
    J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.